Semaglutide to help reduce cannabis use disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests whether a medication called semaglutide (used for weight management) can help adults with cannabis use disorder cut down or stop using cannabis. Researchers want to see if it reduces cravings and use while also monitoring overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You use cannabis at least 16 days per month and want to reduce or quit
- You have a positive urine test for cannabis use in the past 28 days
- You are 18–70 years old with a BMI of at least 23 kg/m² (roughly 5'6" and 160+ lbs, depending on height)
- You do not have other substance use disorders (besides tobacco) or severe mental health conditions like schizophrenia or bipolar disorder in the past 5 years
- You have no history of suicide attempt, severe brain injury, stroke, diabetes, or serious heart disease
- You speak and understand Danish and can follow study procedures for several months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tirzepatide (a medication that affects appetite and metabolism) can help people reduce or stop cannabis use. It is for adults who want treatment for cannabis use disorder.
This trial tests if tirzepatide, a hormone-like medicine, can help people with severe cannabis use disorder reduce their cannabis use. It may work by changing how your body responds to certain signals.
This study tests whether semaglutide, a medication used for weight management, can help reduce cocaine use in people with cocaine use disorder. You may qualify if you have a body mass index (BMI) of 25 or higher and recently used cocaine.
This study tests if the diabetes drug semaglutide (also used for weight loss) can help reduce cocaine use in adults, including those living with HIV. It's free and lasts about 8 weeks.
This trial tests if semaglutide, a medicine sometimes used for weight management, can help people recovering from opioid use disorder stay on track. It is for adults who have already started buprenorphine treatment and are ready to take part in a research study.
This study tests whether semaglutide, a medication that helps with weight loss, can also reduce alcohol cravings and drinking in people with alcohol use disorder. It may help you drink less and lose weight.
Hear when a new Cannabis Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.